IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GRISANTI, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.172
AS - Asia 5.700
EU - Europa 4.141
SA - Sud America 1.112
Continente sconosciuto - Info sul continente non disponibili 335
AF - Africa 153
OC - Oceania 12
Totale 23.625
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.783
SG - Singapore 2.107
CN - Cina 1.477
IT - Italia 988
BR - Brasile 875
HK - Hong Kong 556
DE - Germania 500
UA - Ucraina 457
VN - Vietnam 424
PL - Polonia 422
FI - Finlandia 407
BD - Bangladesh 369
FR - Francia 278
GB - Regno Unito 270
RU - Federazione Russa 244
CA - Canada 207
TR - Turchia 176
IN - India 140
IE - Irlanda 139
AR - Argentina 81
SE - Svezia 69
ID - Indonesia 68
NL - Olanda 68
JP - Giappone 59
CZ - Repubblica Ceca 56
MX - Messico 56
IQ - Iraq 53
LT - Lituania 53
ZA - Sudafrica 50
EC - Ecuador 41
PK - Pakistan 36
IL - Israele 35
AT - Austria 33
BE - Belgio 31
CO - Colombia 31
ES - Italia 31
UZ - Uzbekistan 24
SA - Arabia Saudita 23
VE - Venezuela 23
MA - Marocco 22
CR - Costa Rica 20
AE - Emirati Arabi Uniti 19
CH - Svizzera 18
PY - Paraguay 17
JM - Giamaica 16
PH - Filippine 16
CL - Cile 13
EG - Egitto 13
HN - Honduras 13
AZ - Azerbaigian 12
DZ - Algeria 12
GR - Grecia 12
PE - Perù 12
SV - El Salvador 12
EE - Estonia 11
JO - Giordania 11
KE - Kenya 11
PT - Portogallo 11
TH - Thailandia 11
AU - Australia 10
GT - Guatemala 10
LB - Libano 10
TT - Trinidad e Tobago 10
KZ - Kazakistan 9
NP - Nepal 9
PR - Porto Rico 9
UY - Uruguay 9
NG - Nigeria 8
PA - Panama 8
AL - Albania 7
TW - Taiwan 7
DO - Repubblica Dominicana 6
ET - Etiopia 6
MY - Malesia 6
NI - Nicaragua 6
SC - Seychelles 6
TN - Tunisia 6
CW - ???statistics.table.value.countryCode.CW??? 5
DK - Danimarca 5
GY - Guiana 5
IR - Iran 5
LY - Libia 5
RS - Serbia 5
BG - Bulgaria 4
CY - Cipro 4
KG - Kirghizistan 4
KR - Corea 4
LV - Lettonia 4
MU - Mauritius 4
OM - Oman 4
RO - Romania 4
BO - Bolivia 3
BZ - Belize 3
EU - Europa 3
LK - Sri Lanka 3
MD - Moldavia 3
PS - Palestinian Territory 3
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
Totale 23.250
Salva come PNG Salva come JPEG
Città #
Ashburn 1.166
Singapore 1.123
San Jose 913
Fairfield 746
Hong Kong 545
Woodbridge 532
Council Bluffs 512
Warsaw 412
Houston 408
Dallas 373
New York 344
The Dalles 329
Los Angeles 326
Beijing 320
Seattle 319
Jacksonville 313
Cambridge 306
Chandler 301
Chicago 284
Wilmington 267
Helsinki 263
Princeton 180
Ann Arbor 166
Lauterbourg 155
Ho Chi Minh City 148
Munich 142
Istanbul 137
Columbus 125
Buffalo 122
Santa Clara 120
Salt Lake City 114
Brescia 108
Dublin 105
Milan 96
Moscow 90
São Paulo 89
Nanjing 87
Shanghai 80
Turku 78
Boardman 74
Hanoi 72
Phoenix 71
San Francisco 69
North Bergen 66
Redondo Beach 66
Des Moines 60
Secaucus 58
Tampa 56
Elk Grove Village 53
Jakarta 51
Dearborn 50
Rome 49
London 48
Montreal 48
Brooklyn 47
Orem 47
Atlanta 45
Lancaster 43
Brno 42
Toronto 42
Naples 41
San Diego 40
Vilnius 39
Changsha 38
Washington 38
Frankfurt am Main 37
Nanchang 37
Nuremberg 36
Denver 35
Tokyo 33
Dong Ket 32
Chennai 31
Poplar 31
Dalmine 30
Rio de Janeiro 30
Stockholm 30
Romola 29
Sterling 29
Boston 28
Lappeenranta 28
Shenyang 28
Brussels 26
Da Nang 26
Tianjin 26
West Jordan 26
Belo Horizonte 24
Turin 24
Charlotte 23
Guangzhou 22
Johannesburg 22
Menlo Park 22
Tashkent 22
Amsterdam 21
Hangzhou 21
Jinan 21
Haiphong 20
Las Vegas 20
Vienna 20
Ankara 19
Bergamo 19
Totale 14.525
Salva come PNG Salva come JPEG
Nome #
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 808
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 390
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 299
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 276
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 275
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 265
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 260
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 239
Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy 232
Immunotherapy failure in adrenocortical cancer: where next? 231
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 223
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 222
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 220
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 219
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 218
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 216
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 214
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli 212
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 210
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 209
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 207
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 202
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 201
Progression of vertebral fractures in metastatic melanoma and non-small cell lung cancer patients given immune checkpoint inhibitors 200
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 200
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 195
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 194
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 192
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 187
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial 184
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 180
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 180
Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. 179
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 179
Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer? 178
Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge. 177
Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: A pooled analysis of published cases 175
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 172
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 171
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma 170
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 169
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 168
Aspergillosis superinfection as a cause of death of crizotinib-induced interstitial lung disease successfully treated with high-dose corticosteroid therapy 165
Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial 163
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 163
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 160
Molecular target agents in adrenocortical carcinoma: rationale and difficulties in trial design 159
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 159
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 158
Oncological treatment administration at end of life: a retrospective study 157
Idiopathic intracranial hypertension: A possible complication in the natural history of advanced prostate cancer. 157
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 157
An alternating regimen of irinotecan/ 5-fluorouracil/folinic acid and oxaliplatin/ 5-fluorouracil/folinic acid in metastatic colorectal cancer: a Phase II trial 156
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 154
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort 151
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 151
Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatment 148
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 148
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 148
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 147
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 147
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 146
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 145
Systemic Therapy in Locally Advanced or Metastatic Adrenal Cancers: A Critical Appraisal and Clinical Trial Update 145
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases 144
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 143
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 141
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 141
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 140
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 139
HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study. 138
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 137
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 137
Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma 137
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 136
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis 136
Home-based pulmonary rehabilitation in patients undergoing (chemo)radiation therapy for unresectable lung cancer: a prospective explorative study 134
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 134
Phase II study of sunitinib and irinotecan in patients with recurrent high-grade glioma (HGG) 131
Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs 130
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 130
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 128
Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients? 128
Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs 128
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 127
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group 125
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 125
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 124
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 123
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 122
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? 121
Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. 120
Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation 119
Evaluation of DNA methylation levels of SEPT9 and SHOX2 in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR 116
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 116
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 114
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research 113
Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies 111
Efficacy of immune checkpoint inhibitors (ICIs) in PD-L1 negative Non-Small Cell Lung Cancer (NSCLC) – A meta-analysis based on reconstructed individual participant data 110
Dynamic Susceptibility Contrast MR Imaging inGlioblastomas: Correlation of Whole-TumorHistogram Analysis of the Normalized CerebralBlood Volume and Vascular Permeability withHistopathologic and Molecular Markers of TumorAggressiveness 107
Totale 17.487
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.883
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.883
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022573 0 0 0 0 22 53 36 56 43 108 64 191
2022/2023823 106 53 42 63 70 191 5 74 119 22 44 34
2023/20241.474 71 41 133 93 104 269 46 79 226 69 49 294
2024/20254.477 50 47 62 557 406 297 276 151 457 288 1.014 872
2025/20268.461 667 1.045 733 955 793 554 1.171 333 555 777 502 376
2026/20272.650 376 349 569 1.307 49 0 0 0 0 0 0 0
Totale 23.625